Abstract
Progranulin is a growth and survival factor implicated in tumorigenesis and drug resistance. Several studies showed that progranulin is expressed in breast cancer tissue and inversely correlates with survival. B lymphocyte chemoattractant, also known as B cell-attracting chemokine 1 (BCA-1), is a member of the CXC subtype of the chemokine superfamily. BCA-1 is critical for secondary lymphoid tissue development and navigation of lymphocytes within the microcompartments of the tissue. There are no data on the content of progranulin and BCA-1 in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients. To study this issue, we measured BALF content of progranulin and BCA-1 in 46 NSCLC patients before chemotherapy and 15 healthy subjects. Both markers were elevated in cancer patients compared to healthy subjects (progranulin: 61.4 (1.6–384.0) vs. 6.5 (0.6–12.9) ng/ml, p = 0.001 and BCA-1: 30.8 (24.3–70.8) vs. 15.4 (13.3–19.5) pg/ml, p = 0.0001). The cut-off BALF level concerning NSCLC vs. controls, investigated using the receiver-operating characteristic (ROC) curve, yielded 6.5 ng/ml for progranulin and 15.4 pg/ml for BCA-1. We failed to find any association between the BALF content of progranulin or BCA-1 and the stage of tumor or prospectively assessed treatment response. However, BALF progranulin associated with time to tumor progression (r = 0.61; p = 0.04). In addition, a higher BALF content of BCA-1 in NSCLC patients associated with shorter overall survival. We conclude that progranulin and BCA-1 in BALF of NSCLC patients before chemotherapy may be prognostic factors of cancer progression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abella V, Pino J, Scotece M, Conde J, Lago F, Gonzalez-Gay MA, Mera A, Gómez R, Mobasheri A, Gualillo O (2017) Progranulin as a biomarker and potential therapeutic agent. Drug Discov Today 22(10):1557–1564
Biswas S, Sengupta S, Roy Chowdhury S, Jana S, Mandal G, Mandal PK, Saha N, Malhotra V, Gupta A, Kuprash DV, Bhattacharyya A (2014) CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Breast Cancer Res Treat 143(2):265–276
Bürkle A, Niedermeier M, Schmitt-Gräff A, Wierda WG, Keating MJ, Burger JA (2007) Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 110(9):3316–3325
Cheung ST, Cheung PF, Cheng CK, Wong NC, Fan ST (2011) Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 140(1):344–355
Cuevas-Antonio R, Cancino C, Arechavaleta-Velasco F, Andrade A, Barron L, Estrada I, Fernandez RL, Olguin V, Ruiz S, Imani F, Zeferino-Toquero M, Ulloa-Aguirre A, Gerton GL, Diaz-Cueto L (2010) Expression of progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line. Cancer Investig 28(5):452–458
Daniel R, He Z, Carmichael KP, Halper J, Bateman A (2000) Cellular localization of gene expression for progranulin. J Histochem Cytochem 48(7):999–1009
Duan Z, Gao J, Zhang L, Liang H, Huang X, Xu Q, Zhang Y, Shen T, Lu F (2015) Phenotype and function of CXCR5+CD45RA-CD4+ T cell were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis. Oncotarget 6(42):44239–44253
Edelman MJ, Feliciano J, Yue B, Bejarano P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D, Serrero G (2014) GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma. Hum Pathol 45(9):1893–1899
Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT (1998) A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1. Nature 391(6669):799–803
Hu Y, Xiao H, Shi T, Oppenheim JJ, Chen X (2014) Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4+ Foxp3+ regulatory T cells. Immunology 142(2):193–201
Lee CY, Shim HS, Lee S, Lee JG, Kim DJ, Chung KY (2015) Prognostic effect of matrix metalloproteinase-9 in patients with resected non-small cell lung cancer. J Cardiothorac Surg 10:44
Lee KY, Park SY, Park S, Hong GH, Moon KA, Kim YS, Oh YM, Kwon HS, Kim TB, Moon HB, Cho YS (2017) Progranulin protects lung epithelial cells from cigarette smoking-induced apoptosis. Respirology 22(6):1140–1148
Merchant N, Nagaraju GP, Rajitha B, Lammata S, Jella KK, Buchwald ZS, Lakka SS, Ali AN (2017) Matrix metalloproteinases: their functional role in lung cancer. Carcinogenesis 38(8):766–780
Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo JR, Burkhardt M, Kulkarni V, Crispino J, Hering H, Hutton M (2011) Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am J Pathol 178(1):284–295
Qi XW, Xia SH, Yin Y, Jin LF, Pu Y, Hua D, Wu HR (2014) Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer. Eur Rev Med Pharmacol Sci 18(13):1916–1924
Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee (2014) The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 9(11):1618–1624
Sambandam Y, Sundaram K, Liu A, Kirkwood KL, Ries WL, Reddy SV (2013) CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment. Oncogene 32(1):97–105
Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK (2013) Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst 105(24):1871–1880
Singh R, Gupta P, Kloecker GH, Singh S, Lillard JW (2014) Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma. Int J Oncol 45(6):2232–2240
Tangkeangsirisin W, Serrero G (2004) PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25(9):1587–1592
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216
Wang GZ, Cheng X, Zhou B, Wen ZS, Huang YC, Chen HB, Li GF, Huang ZL, Zhou YC, Feng L, Wei MM, Qu LW, Cao Y, Zhou GB (2015) The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution. elife 13:4
Wei Y, Lin C, Li H, Xu Z, Wang J, Li R, Liu H, Zhang H, He H, Xu J (2018) CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Cancer Immunol Immunother 67(2):261–269
Xu D, Suenaga N, Edelmann MJ, Fridman R, Muschel RJ, Kessler BM (2008) Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics 7(11):2215–2228
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Ethical Approval
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study protocol was approved by the Bioethics Committee of the Medical University of Bialystok in Poland.
Informed Consent
Informed written consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Naumnik, W., Panek, B., Ossolińska, M., Naumnik, B. (2018). B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors. In: Pokorski, M. (eds) Pulmonary Health and Disorders. Advances in Experimental Medicine and Biology(), vol 1150. Springer, Cham. https://doi.org/10.1007/5584_2018_285
Download citation
DOI: https://doi.org/10.1007/5584_2018_285
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17778-2
Online ISBN: 978-3-030-17779-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)